Fund HoldingsCheckpoint Capital L.P.

Total Portfolio Value
$389.76M
Total Bought
$80.72M
Total Sold
$39.66M
Net Transaction
+$41.06M
Filing Period:
Securities
SharesValue ($K)
Q1 2026
Q2 2026
Change
Q1 2026
Q2 2026
Weight (%)
Change
REVOLUTION MEDICINES INC(RVMD)262,539410,353+147,81425,53276,85119.72%+51,319
CYTOKINETICS INC(CYTK)180,000475,000+295,00011,86440,46510.38%+28,601
RHYTHM PHARMACEUTICALS INC(RYTM)1,227,2001,186,000-41,200106,730131,68233.79%+24,952
ARGENX SE(ARGX)153,000131,283-21,717111,728121,80031.25%+10,072
TREVI THERAPEUTICS INC(TRVI)50,00075,000+25,0005971,3990.36%+802
DISC MEDICINE INC(IRON)286,661240,125-46,53618,32917,5634.51%-766
CRINETICS PHARMACEUTICALS IN(CRNX)40,2300-40,2301,4610-1,461
SEPTERNA INC(SEPN)100,3000-100,3002,4100-2,410
Page 1 of 1
Checkpoint Capital L.P. — 13F Holdings — Q2 2026 | TickerTrail